רקומבינאט IU 250

Country: ইস্রায়েল

ভাষা: হিব্রু

সূত্র: Ministry of Health

সক্রিয় উপাদান:

COAGULATION FACTOR VIII RECOMBINANT 250 IU/VIAL

থেকে পাওয়া:

TEVA MEDICAL MARKETING LTD.

এটিসি কোড:

B02BD02

ফার্মাসিউটিকাল ফর্ম:

POWDER FOR SOLUTION FOR INJECTION

প্রশাসন রুট:

I.V

Manufactured by:

BAXTER S.A., BELGIUM

Therapeutic group:

COAGULATION FACTOR VIII

থেরাপিউটিক ইঙ্গিত:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

অনুমোদন তারিখ:

2010-07-01